Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dixit

Showing results (91-100 of 501) with videos related to

Pageof 51
Sort By:
Nature Communications|May 20, 2014
Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatmentPranesh Padmanabhan, Urtzi Garaigorta, Narendra M Dixit
Experientia|January 15, 1990
Plasma lipid-bound sialic acid alterations in neoplastic diseasesC Dwivedi, M Dixit, R E Hardy
Immunology and Cell Biology|May 11, 2018
Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agentsSubhasish Baral, Rahul Roy, Narendra M Dixit
Immunological Reviews|August 22, 2018
Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment eraRubesh Raja, Subhasish Baral, Narendra M Dixit
Nature Computational Science|January 4, 2024
Modeling how antibody responses may determine the efficacy of COVID-19 vaccinesPranesh Padmanabhan, Rajat Desikan, Narendra M Dixit
Biochemistry|August 17, 2019
Steering the Lipid Transfer To Unravel the Mechanism of Cholesteryl Ester Transfer Protein InhibitionSneha M Dixit, Mohd Ahsan, Sanjib Senapati
The Journal of Biological Chemistry|August 18, 1995
Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinaseA Pandey, H Duan, V M Dixit
Journal of Analytical Toxicology|January 1, 1992
Solid-phase extraction and GC/MS confirmation of barbiturates from human urineR Pocci, V Dixit, V M Dixit
Trends in Pharmacological Sciences|October 16, 2019
You Cannot Have Your Synergy and Efficacy TooPramita Sen, Ananya Saha, Narendra M Dixit
American Journal of Preventive Cardiology|September 10, 2024
Will DANCAVAS be the most important screening trial in the last 50 years?Neal M Dixit, Edward Chau, Saul Schaefer
Pageof 51

Showing results (91-100 of 501) with videos related to

Sort By:
Pageof 51
Nature Communications|May 20, 2014
Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatmentPranesh Padmanabhan, Urtzi Garaigorta, Narendra M Dixit
Experientia|January 15, 1990
Plasma lipid-bound sialic acid alterations in neoplastic diseasesC Dwivedi, M Dixit, R E Hardy
Immunology and Cell Biology|May 11, 2018
Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agentsSubhasish Baral, Rahul Roy, Narendra M Dixit
Immunological Reviews|August 22, 2018
Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment eraRubesh Raja, Subhasish Baral, Narendra M Dixit
Nature Computational Science|January 4, 2024
Modeling how antibody responses may determine the efficacy of COVID-19 vaccinesPranesh Padmanabhan, Rajat Desikan, Narendra M Dixit
Biochemistry|August 17, 2019
Steering the Lipid Transfer To Unravel the Mechanism of Cholesteryl Ester Transfer Protein InhibitionSneha M Dixit, Mohd Ahsan, Sanjib Senapati
The Journal of Biological Chemistry|August 18, 1995
Characterization of a novel Src-like adapter protein that associates with the Eck receptor tyrosine kinaseA Pandey, H Duan, V M Dixit
Journal of Analytical Toxicology|January 1, 1992
Solid-phase extraction and GC/MS confirmation of barbiturates from human urineR Pocci, V Dixit, V M Dixit
Trends in Pharmacological Sciences|October 16, 2019
You Cannot Have Your Synergy and Efficacy TooPramita Sen, Ananya Saha, Narendra M Dixit
American Journal of Preventive Cardiology|September 10, 2024
Will DANCAVAS be the most important screening trial in the last 50 years?Neal M Dixit, Edward Chau, Saul Schaefer
Pageof 51